Beta-2 Microglobulin (Serum)
Beta-2 microglobulin (B2M) is a protein found on the surface of most nucleated cells and is shed into the blood, making it useful for assessing kidney function.
Beta-2 microglobulin is a diagnostic biomarker for evaluating kidney function.
Key facts at a glance
- Units
- μg/mL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche Beta-2-Microglobulin, Abbott Beta-2-Microglobulin
Beta-2 microglobulin (B2M) is a small protein that is a component of the major histocompatibility complex (MHC) class I molecules and is present on the surface of nearly all nucleated cells. It is shed into the bloodstream and filtered by the kidneys, where it is normally reabsorbed and metabolized.
In conditions where kidney function is impaired, the levels of B2M in the blood can rise due to decreased filtration and clearance. This makes it a valuable biomarker for diagnosing and monitoring renal diseases.
The reference range for serum B2M is typically between 0.7 and 1.8 μg/mL. Elevated levels may indicate renal dysfunction, while lower levels are less common and may be associated with certain immunological conditions.
Frequently asked questions
What conditions can cause elevated B2M levels?
How is the B2M test performed?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy